Association of Dutch Burn Centres, Maasstad Hospital, Rotterdam, The Netherlands; Department of Plastic, Reconstructive and Hand Surgery, MOVE Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
Association of Dutch Burn Centres, Red Cross Hospital, Beverwijk, The Netherlands.
Burns. 2014 May;40(3):388-96. doi: 10.1016/j.burns.2013.08.025. Epub 2013 Sep 13.
A recently performed randomised controlled trial investigated the clinical effectiveness of dermal substitutes (DS) and split skin grafts (SSG) in combination with topical negative pressure (TNP) in the surgical treatment of burn wounds. In the current study, medical and non-medical costs were investigated, to comprehensively assess the benefits of this new treatment.
The primary outcome was mean total costs of the four treatment strategies: SSG with or without DS, and with or without TNP. Costs were studied from a societal perspective. Findings were evaluated in light of the clinical effects on scar elasticity.
Eighty-six patients were included. Twelve months post-operatively, highest elasticity was measured in scars treated with DS and TNP (p=0.027). The initial cost price of treatment with DS and TNP was €2912 compared to treatment with SSG alone €1703 (p<0.001). However, mean total costs per patient did not differ significantly between groups (range €29097-€43774).
Costs of the interventional treatment contributed maximal 7% to the total costs and total costs varied widely within and between groups, but were not significantly different. Therefore, in the selection of the most optimal type of surgical intervention, cost considerations should not play an important role.
最近进行的一项随机对照试验研究了真皮替代物(DS)和刃厚皮片(SSG)与负压创面治疗(TNP)联合应用于烧伤创面外科治疗的临床效果。在本研究中,我们调查了医疗和非医疗成本,以全面评估这种新治疗方法的效益。
主要结局为四种治疗策略的平均总费用:带或不带 DS 的 SSG,以及带或不带 TNP 的 SSG。从社会角度研究成本。根据对瘢痕弹性的临床效果评估结果。
共纳入 86 例患者。术后 12 个月,DS 和 TNP 治疗的瘢痕弹性最高(p=0.027)。DS 和 TNP 治疗的初始治疗费用为 2912 欧元,而单独使用 SSG 治疗的费用为 1703 欧元(p<0.001)。然而,各组患者的平均总费用无显著差异(范围为 29097-43774 欧元)。
干预治疗的费用仅占总费用的最大 7%,且总费用在组内和组间差异很大,但无统计学意义。因此,在选择最优化的手术干预类型时,成本因素不应起重要作用。